- 肿瘤治疗中的生物反应调节剂 -...
- 幽门螺杆菌感染治疗新进展
- 中华慈善总会间质瘤GIPAP项...
- 胃癌发展过程中各阶段化疗药物及...
- 医院盲目扩张为何让“看病更贵”...
- 2011版美国NCCN胃癌规约...
- 癌症死亡率胃癌占2成以上 饥一...
- 胃息肉的相关术语解读
- 胃癌治疗方法与优缺点
- 慢性萎缩性胃炎的相关知识
- 慢性胃炎的保养措施
- 胆汁反流性胃炎的中西医结合治疗
- 手术中使用的吻合器,闭合器等辅...
- “超级细菌”抗生素耐药病菌
- 《心术》-- 细说医患关系问题...
- 慢性胃炎的诊断和治疗
- 浅表性胃炎的防治
- 胆汁反流性胃炎的诊治
- 幽门螺旋杆菌的发现
- 幽门螺旋杆菌杆菌与胃部疾病
- 胃癌的病理类型及转移途径
- 胃癌的临床症状
- 胃癌手术有关的胃分区、胃周淋巴...
- 胃癌发病率比30年前翻一番 不...
- 胃癌术后复查应如何进行?
- 胃大部切除后的营养
- 胃切除术后营养不良
- The impact of a...
- Chemosensitivit...
- The difference ...
- Exclusive KRAS ...
- High-resolution...
- Microsatellite ...
- Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer
- 作者:赵岩|发布时间:2010-04-10|浏览量:642次
Oki E, Zhao Y, Yoshida R, Masuda T, Ando K, Sugiyama M, Tokunaga E, Morita M, Kakeji Y, Maehara Y.
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Abstract
AIM: To examine the methylation status of the promoter region of the checkpoint with forkhead-associated and ring finger (CHFR) and microsatellite mutator status in 59 primary gastric cancers. METHODS: We investigated the promoter methylation of CHFR in 59 cases of gastric cancer using methylation-specific PCR. Five microsatellite loci were analyzed using high-intensity microsatellite analysis reported previously, and p53 gene mutations were investigated by direct sequencing. RESULTS: Twenty cases (33.9%) showed promoter methylation and no relation was observed with the clinicopathological factors. We found that the promoter methylation of CHFR was frequently accompanied with microsatellite instability (MIN). Seven of 20 (35.0%) cases showed MIN in hypermethylation of the CHFR tumor, while three of 39 (7.7%) cases showed MIN in the non-methylated CHFR tumor (P < 0.01). However, we failed to find any relationship between CHFR methylation and p53 mutation status. CONCLUSION: The coordinated loss of both the mitotic check point function and mismatch repair system suggests the potential to overcome the cell cycle check point, which may lead to an accumulation of mutations. However, the p53 mutation was not related to hypermethylation of the CHFR promoter and MIN, which indicates that an abnormality in p53 occurs as an independent process from the mismatch repair deficiency in carcinogenesis.辽宁省肿瘤医院胃科赵岩
PMID: 19469003
TA的其他文章: